Harte Hanks (HHS) Shares Outstanding (Diluted Average) (2016 - 2025)
Harte Hanks has reported Shares Outstanding (Diluted Average) over the past 16 years, most recently at $7.4 million for Q4 2025.
- Quarterly Shares Outstanding (Diluted Average) rose 1.37% to $7.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.4 million through Dec 2025, up 1.37% year-over-year, with the annual reading at $7.4 million for FY2025, 1.37% up from the prior year.
- Shares Outstanding (Diluted Average) was $7.4 million for Q4 2025 at Harte Hanks, roughly flat from $7.4 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $7.5 million in Q3 2023 and troughed at $6.7 million in Q1 2021.
- The 5-year median for Shares Outstanding (Diluted Average) is $7.3 million (2022), against an average of $7.3 million.
- Year-over-year, Shares Outstanding (Diluted Average) increased 11.47% in 2021 and then decreased 3.3% in 2024.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $7.2 million in 2021, then grew by 3.44% to $7.5 million in 2022, then decreased by 1.97% to $7.3 million in 2023, then dropped by 0.23% to $7.3 million in 2024, then rose by 1.37% to $7.4 million in 2025.
- Per Business Quant, the three most recent readings for HHS's Shares Outstanding (Diluted Average) are $7.4 million (Q4 2025), $7.4 million (Q3 2025), and $7.4 million (Q2 2025).